Abstract
Prostate cancer is the most frequently diagnosed solid malignancy in men. Epidemiological studies have shown African-American men to be at higher risk for developing prostate cancer and experience higher death as compared to other ethnic groups. Establishment of prostate cancer cell lines paired with normal cells derived from the same patient is a fundamental breakthrough in cell culture technology and provides a resource to improve our understanding of cancer development and pertinent molecular events. Previous studies have demonstrated that conditional reprogramming (CR) allows the establishment and propagation of patient-derived normal and tumor epithelial cell cultures from a variety of tissue types. Here, we report a new AA prostate cell model, paired normal and cancer epithelial cells from the same patient. “Tumor” cell culture AA-103A was derived from malignant prostate tissues, and “normal” cell culture AA-103B was derived from non-malignant prostate tissues from the prostatectomy specimen of an African-American male. These paired cell cultures have been propagated under CRC conditions to permit direct comparison of the molecular and genetic profiles of the normal epithelium and adenocarcinoma cells for comparison of biomarkers, enabling patient-specific pathological analysis, and molecular and cellular characterization. STR confirmed human origin albeit no karyotypic abnormalities in the two cell lines. Further quantitative PCR analyses demonstrated characteristic markers, including the high level of basal cell marker, the keratin 5 (KRT5) in normal cells and of luminal marker, the androgen receptor (AR) as well as the programmed death-ligand 1 (PD-L1) in tumor cells. Although 3-D sphere formation was observed, the AA-103A of tumor cells did not generate tumors in vivo. We report these paired primary epithelial cultures under CRC growth as a potentially useful tool for studies to understand molecular mechanisms underlying health disparities in prostate cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chornokur, G., Dalton, K., Borysova, M. E., & Kumar, N. B. (2011). Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate, 71(9), 985–997.
Cohen, J. H., Schoenbach, V. J., Kaufman, J. S., Talcott, J. A., Schenck, A. P., Peacock, S., et al. (2006). Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes & Control, 17(6), 803–811.
Evans, S., Metcalfe, C., Ibrahim, F., Persad, R., & Ben-Shlomo, Y. (2008). Investigating black-white differences in prostate cancer prognosis: A systematic review and meta-analysis. International Journal of Cancer, 123(2), 430–435.
Thompson, I., Tangen, C. M., Tolcher, A., Crawford, E. D., Eisenberger, M., & Moinpour, C. M. (2001). Association of African-American ethnic background with survival in men with metastatic prostate cancer. Journal of the National Cancer Institute, 93(3), 219–225.
Albain, K. S., Unger, J. M., Crowley, J. J., Coltman, C. A., & Hershman, D. L. (2009). Racial disparities in cancer survival among randomized clinical trials patients of the southwest oncology group. Journal of the National Cancer Institute, 101(14), 984–992.
Ross, R., Bernstein, L., Judd, H., Hanisch, R., Pike, M., & Henderson, B. (1986). Serum testosterone levels in healthy young black and white men. Journal of the National Cancer Institute, 76(1), 45–48.
Gaston, K. E., Kim, D., Singh, S., Ford, O. H., Mohler, J. L., et al. (2003). Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. The Journal of Urology, 170(3), 990–993.
Timofeeva, O. A., Zhang, X., Ressom, H. W., Varghese, R. S., Kallakury, B. V., Wang, K., et al. (2009). Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men. International Journal of Oncology, 35(4), 751–760.
Wallace, T. A., Prueitt, R. L., Yi, M., Howe, T. M., Gillespie, J. W., Yfantis, H. G., et al. (2008). Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Research, 68(3), 927–936.
Liu, X., Ory, V., Chapman, S., Yuan, H., Albanese, C., Kallakury, B., et al. (2012). ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. The American Journal of Pathology, 180(2), 599–607.
Liu, X., Krawczyk, E., Suprynowicz, F. A., Palechor-Ceron, N., Yuan, H., et al. (2017). Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens. Nature Protocols, 12(2), 439–451.
Timofeeva, O. A., Palechor-Ceron, N., Li, G., Yuan, H., Krawczyk, E., Zhong, X., et al. (2017). Conditionally reprogrammed normal and primary tumor prostate epithelial cells: A novel patient-derived cell model for studies of human prostate cancer. Oncotarget, 8(14), 22741–22758.
Acknowledgments
This work was supported by the NIH/NCI SBIR contract number HHSN261201600038C to Shuttle Pharmaceuticals, Inc.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nicolas, N. et al. (2019). African-American Prostate Normal and Cancer Cells for Health Disparities Research. In: Rhim, J., Dritschilo, A., Kremer, R. (eds) Human Cell Transformation. Advances in Experimental Medicine and Biology, vol 1164. Springer, Cham. https://doi.org/10.1007/978-3-030-22254-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-22254-3_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22253-6
Online ISBN: 978-3-030-22254-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)